Comparison of Two RNA Extraction Methods for the Molecular Detection of SARS-CoV-2 from Nasopharyngeal Swab Samples
Open Access
- 27 June 2022
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 12 (7), 1561
- https://doi.org/10.3390/diagnostics12071561
Abstract
Background: Rapid diagnosis of COVID-19 is essential in order to restrict the spread of the pandemic, and different approaches for SARS-CoV-2 testing have been proposed as cost-effective and less time-consuming alternatives. For virus detection, the real-time reverse transcriptase–polymerase chain reaction (RT-PCR) technique is still the “gold standard” for accuracy and reliability, but its performance is affected by the efficiency of nucleic acid extraction methods. Objective: In order to improve the SARS-CoV-2 diagnostic workflow, we compared a “standard” commercially available kit, based on viral RNA extraction from human swab samples by magnetic beads, with its technological evolution. The two methods differ mainly in their time consumption (9 vs. 35 min). Methods: We adopted the MAGABIO PLUS VIRUS DNA/RNA PURIFICATION KIT II (BIOER), defined as “standard”, with the automatic extractor BIOER (GenePure Pro fully automatic nucleic acid purification system) to isolate RNA from nasopharyngeal swabs for the detection of SARS-CoV-2 by RT-PCR. We tested this kit with a new faster version of the first one, defined as “rapid” (MAGABIO PLUS VIRUS RNA PURIFICATION KIT II). Results and Conclusion: The two evaluated procedures provided similar analytical results, but the faster method proved to be a more suitable tool for the detection of SARS-CoV-2 from nasopharyngeal swabs, due to a more rapid availability of results, which may contribute to improving both clinical decision making and patient safety.Keywords
This publication has 18 references indexed in Scilit:
- RNA‐dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID‐19Cancer Science, 2020
- Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related VirusesmBio, 2020
- Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approachBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Comparison of procedures for RNA-extraction from peripheral blood mononuclear cellsPLOS ONE, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle EastEmerging Microbes & Infections, 2020
- RNA Dependent RNA Polymerases: Insights from Structure, Function and EvolutionViruses, 2018
- Genome-wide identification of interferon-sensitive mutations enables influenza vaccine designScience, 2018
- The Interferon Signaling Antagonist Function of Yellow Fever Virus NS5 Protein Is Activated by Type I InterferonCell Host & Microbe, 2014
- RNA integrity and the effect on the real-time qRT-PCR performanceMolecular Aspects of Medicine, 2006